Hospital
Northwest Medical Foundation of Tillamook
Northwest Medical Foundation of Tillamook was paid $22.37M by Medicaid between Jan 2018 and Dec 2024, across 126 billing codes. Its largest line is 99284, emergency room visit (serious) — 28% of everything it billed.
33Billing provider infoNORTHWEST MEDICAL FOUNDATION OF TILLAMOOK
TILLAMOOK, OR 97141
TILLAMOOK, OR 97141
33aNPI1871575225assigned 11/18/2005
33bProvider typeCritical Access Hospital
28Total paid$22.37M
24GClaims257,262
24DCodes billed126
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Oregon
Rank by total paid#2 of 22
Median peer was paid$3.52M
This provider vs. median6.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 33,480 | $3.21M | |
| 2019 | 31,475 | $3.07M | |
| 2020 | 26,477 | $2.55M | |
| 2021 | 38,315 | $2.86M | |
| 2022 | 46,975 | $3.64M | |
| 2023 | 46,314 | $3.79M | |
| 2024incomplete | 34,226 | $3.24M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 28% | 21,845 | 14,486 | $6.16M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 54,566 | 40,517 | $3.48M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 16,358 | 10,982 | $3.34M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 15% | 8,284 | 4,924 | $3.25M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 33,234 | 22,661 | $2.76M |
| 80053 | Comprehensive metabolic panel | 1.7% | 15,265 | 12,274 | $377K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 16,513 | 13,005 | $310K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,425 | 764 | $213K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 2,300 | 1,848 | $199K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,551 | 1,390 | $162K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 1,701 | 1,168 | $129K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 1,277 | 868 | $125K |
114 more codes
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,000 | $122K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 7,290 | $122K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,209 | $115K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 677 | $96K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,181 | $93K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,444 | $88K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 677 | $84K |
| 80061 | Lipid panel | <1% | 2,225 | $78K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 292 | $65K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 3,064 | $60K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 663 | $60K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 388 | $52K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,520 | $46K |
| 71045 | Radiologic examination, chest; single view | <1% | 673 | $40K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 448 | $38K |
| 92504 | <1% | 1,158 | $37K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 342 | $33K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 940 | $32K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 835 | $32K |
| 90837 | Psychotherapy session, about an hour | <1% | 533 | $29K |
| 81001 | <1% | 1,520 | $27K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 414 | $26K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,558 | $23K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 184 | $20K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 295 | $18K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 170 | $17K |
| D0191 | <1% | 2,867 | $17K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 184 | $16K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 245 | $15K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 264 | $15K |
| 99188 | <1% | 1,845 | $14K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 44 | $14K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 296 | $14K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 273 | $13K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 135 | $13K |
| 84484 | <1% | 358 | $13K | |
| 85027 | <1% | 516 | $12K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 450 | $12K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 56 | $12K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 105 | $10K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 37 | $10K |
| 87641 | <1% | 157 | $10K | |
| J3490 | Unclassified drugs | <1% | 448 | $9K |
| 82607 | <1% | 225 | $9K | |
| J2704 | Injection, propofol, 10 mg | <1% | 214 | $8K |
| 88142 | <1% | 137 | $8K | |
| 82728 | <1% | 246 | $7K | |
| 81003 | <1% | 403 | $7K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 299 | $7K |
| 87081 | <1% | 225 | $7K | |
| 83690 | <1% | 149 | $6K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 30 | $6K |
| 98926 | <1% | 121 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 357 | $6K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 164 | $6K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 32 | $6K |
| 20610 | <1% | 74 | $6K | |
| 83655 | <1% | 99 | $6K | |
| 86803 | <1% | 158 | $6K | |
| 31231 | <1% | 50 | $6K | |
| 87522 | Neg quan hep c or qual rna | <1% | 31 | $5K |
| 84466 | <1% | 218 | $5K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 342 | $5K |
| 92567 | <1% | 270 | $5K | |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 36 | $4K |
| 83540 | <1% | 266 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 151 | $4K |
| 92557 | <1% | 96 | $4K | |
| 99205 | Prolong outpt/office vis | <1% | 25 | $4K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 24 | $3K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 34 | $3K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 181 | $3K |
| 90686 | <1% | 265 | $3K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 43 | $3K |
| 84439 | <1% | 68 | $2K | |
| 31575 | <1% | 13 | $2K | |
| 87210 | <1% | 89 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 143 | $2K |
| 86705 | <1% | 50 | $1K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 18 | $1K |
| 82962 | <1% | 174 | $1K | |
| 82977 | <1% | 168 | $1K | |
| 99442 | <1% | 52 | $1K | |
| 73562 | <1% | 26 | $1K | |
| 82948 | <1% | 138 | $1K | |
| 87653 | <1% | 12 | $1K | |
| 73630 | <1% | 50 | $898.06 | |
| 83615 | <1% | 70 | $832.02 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 113 | $728.65 |
| 85018 | <1% | 42 | $696.88 | |
| 99174 | <1% | 78 | $583.00 | |
| 87400 | <1% | 33 | $563.12 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 22 | $520.58 |
| 87070 | <1% | 14 | $515.11 | |
| 0001A | <1% | 12 | $498.80 | |
| 90480 | <1% | 12 | $480.00 | |
| 90474 | <1% | 39 | $454.54 | |
| 90473 | <1% | 27 | $449.50 | |
| 83735 | <1% | 14 | $428.01 | |
| Q2036 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | <1% | 51 | $385.84 |
| G0451 | Development testing, with interpretation and report, per standardized instrument form | <1% | 1,658 | $374.24 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 12 | $365.40 |
| 90715 | <1% | 13 | $339.96 | |
| 83721 | <1% | 14 | $303.64 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,133 | $241.44 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 16 | $186.60 |
| A0425 | Ground mileage, per statute mile | <1% | 80 | $183.75 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 21 | $175.37 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 12 | $75.96 |
| 1160F | 0% | 8,456 | $0.00 | |
| 1159F | 0% | 13,496 | $0.00 | |
| 84145 | 0% | 15 | $0.00 | |
| 3008F | 0% | 4,532 | $0.00 | |
| 3079F | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMITH, MICAH (CFO/ADMINISTRATIVE DIRECTOR OF FINA)
| Provider | Location | Paid |
|---|---|---|
| Northwest Medical Foundation of Tillamook | Tillamook, OR | $647K |
| Northwest Medical Foundation of Tillamook | Tillamook, OR | $6K |
| Northwest Medical Foundation of Tillamook | Pacific City, OR | $2K |
| Northwest Medical Foundation of Tillamook | Manzanita, OR | $1K |
| Northwest Medical Foundation of Tillamook | Tillamook, OR | $369.13 |
| Northwest Medical Foundation of Tillamook | Sheridan, OR | $87.98 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.